Corporate announcements

In continuation to our letter dated October 28, 2026 regarding the prior intimation of Board meeting and pursuant to Regulation 51 read with Part B of Schedule III and Regulation 52 and 54 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, (as amended from time to time) ('Listing Regulations'), we hereby inform that the Board of Directors ('Board') of Namdev Finvest Limited (Formerly Known as Namdev Finvest Private Limited ('Company') at its meeting held today i.e. Tuesday, November 03, 2026, has, inter-alia, considered and approv

In continuation to our letter dated October 28, 2026 regarding the prior intimation of Board meeting and pursuant to Regulation 51 read with Part B of Schedule III and Regulation 52 and 54 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, (as amended from time to time) ('Listing Regulations'), we hereby inform that the Board of Directors ('Board') of Namdev Finvest Limited (Formerly Known as Namdev Finvest Private Limited ('Company') at its meeting held today i.e. Tuesday, November 03, 2026, has, inter-alia, considered and approv

In continuation to our letter dated October 28, 2026 regarding the prior intimation of Board meeting and pursuant to Regulation 51 read with Part B of Schedule III and Regulation 52 and 54 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, (as amended from time to time) ('Listing Regulations'), we hereby inform that the Board of Directors ('Board') of Namdev Finvest Limited (Formerly Known as Namdev Finvest Private Limited ('Company') at its meeting held today i.e. Tuesday, November 03, 2026, has, inter-alia, considered and approv

In continuation to our letter dated October 28, 2026 regarding the prior intimation of Board meeting and pursuant to Regulation 51 read with Part B of Schedule III and Regulation 52 and 54 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, (as amended from time to time) ('Listing Regulations'), we hereby inform that the Board of Directors ('Board') of Namdev Finvest Limited (Formerly Known as Namdev Finvest Private Limited ('Company') at its meeting held today i.e. Tuesday, November 03, 2026, has, inter-alia, considered and approv

In continuation to our letter dated October 28, 2026 regarding the prior intimation of Board meeting and pursuant to Regulation 51 read with Part B of Schedule III and Regulation 52 and 54 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, (as amended from time to time) ('Listing Regulations'), we hereby inform that the Board of Directors ('Board') of Namdev Finvest Limited (Formerly Known as Namdev Finvest Private Limited ('Company') at its meeting held today i.e. Tuesday, November 03, 2026, has, inter-alia, considered and approv

In continuation to our letter dated October 28, 2026 regarding the prior intimation of Board meeting and pursuant to Regulation 51 read with Part B of Schedule III and Regulation 52 and 54 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, (as amended from time to time) ('Listing Regulations'), we hereby inform that the Board of Directors ('Board') of Namdev Finvest Limited (Formerly Known as Namdev Finvest Private Limited ('Company') at its meeting held today i.e. Tuesday, November 03, 2026, has, inter-alia, considered and approv

Unaudited Financial Results for the Quarter ended on September 30, 2026.

Please find attached communication sent to shareholders for intimation on TDS on 1st Interim Dividend FY 2026-27.

Un-audited financial results (Standalone & Consolidated) for the quarter and half year ended 30th September, 2026

Biofil Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve Unaudited Financial Results of The Company for The Quarter and Half Year Ended on 30th September, 2026 along with Limited Review Report thereon.

Eicher Motors Limited has informed the Exchange regarding a press release dated November 03, 2026, titled "Royal Enfield at EICMA 2026: The new frontier of Pure Motorcycling and Launch of Royal Enfield Himalayan 750".

The Board of Directors of the Company at their Meeting held today, i.e., Tuesday, 3rd November, 2026 had inter alia considered and approved: The Unaudited Standalone and Consolidated Financial Results of the Company along with Limited Review Report thereon for the quarter and half year ended 30th September, 2026; The appointment of Mr. Seshukumar Venkata Satya Chilukuri (DIN: 07171754) as an Additional Director (Non-Executive Non-Independent Category) of the Company; The appointment of Mr. Sandesh Khandelwal (DIN: 03019887) as an Additional Director (Non-Executive Non-Independent Category) of

Deep Industries Limited has informed the Exchange regarding a press release dated November 03, 2026, titled "Press release for the quarter and half year ended on September 30, 2026".

- Royal Enfield at EICMA 2026: The new frontier of Pure Motorcycling - A return to Pure adventure: Launch of Royal Enfield Himalayan 750

Rbz Jewellers Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

Announcement under Regulation 30 (LODR)-Investor Presentation

Intimation about minor fire incident at the Company''s Plant located in E-15, MIDC, Tarapur, Boisar- 401506, Thane, Maharashtra on 01.11.2026.

Emcure Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

Intimation regarding change in the Corporate Office of the Registrar and Share Transfer Agent (RTA) of the Company

Intimation for holding an Earnings Conference Call to discuss the un-audited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026.

Monitoring Agency Report issued by CARE Ratings Limited for the quarter ended on 30.09.2026

Please find enclosed herewith the Newspaper Publication

Pursuant to Regulation 30 of SEBI (LODR)- Intimation of Appointment of Chief Financial Officer (CFO) and Key Managerial Personnel (KMP) of the Company

Unaudited (Standalone and Consolidated) Financial Results for the Quarter and Half year ended September 30, 2026.

Jocil Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

Intimation about publication of un audited results for quarter ended 30th september 2026

Monitoring Agency Report for the quarter ended on September 30, 2026

We hereby attaching herewith outcome of board meeting of the company. Kindly take the same on your record.

Pls find attached herewith Newspaper Publication of Unaudited Financial Results for the Quarter and Half Year ended 30th September, 2026.

Clarification regarding increase in the volume of securities of ITI Limited for e-mail dated 2nd November 2026.

Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, please find attached the transcript of the earnings conference call held on October 29, 2026, for the quarter ended on September 30, 2026.

OUTCOME OF THE BOARD MEETING OF STANDARD INDUSTRIES LIMITED HELD ON 03RD NOVEMBER, 2026

Intimation for Repayment of Commercial Paper, pursuant to SEBI Master Circular dated October 15, 2025.

For approval of Unaudited Financial Results (Standalone and Consolidated) for the quarter and half-year ended September 30, 2026.

Pursuant to Regulation 52(7) & 52(7A) of SEBI LODR, please find attached statement of utilisation and statement of deviation for quarter ended September 30, 2026.

Pursuant to Regulation 52(7) & 52(7A) of SEBI LODR, please find attached statement of utilisation and statement of deviation for quarter ended September 30, 2026.

Pursuant to Regulation 52(7) & 52(7A) of SEBI LODR, please find attached statement of utilisation and statement of deviation for quarter ended September 30, 2026.

Pursuant to Regulation 52(7) & 52(7A) of SEBI LODR, please find attached statement of utilisation and statement of deviation for quarter ended September 30, 2026.

Pursuant to Regulation 52(7) & 52(7A) of SEBI LODR, please find attached statement of utilisation and statement of deviation for quarter ended September 30, 2026.

Pursuant to Regulation 52(7) & 52(7A) of SEBI LODR, please find attached statement of utilisation and statement of deviation for quarter ended September 30, 2026.

Pursuant to Regulation 52(7) & 52(7A) of SEBI LODR, please find attached statement of utilisation and statement of deviation for quarter ended September 30, 2026.

Pursuant to Regulation 52(7) & 52(7A) of SEBI LODR, please find attached statement of utilisation and statement of deviation for quarter ended September 30, 2026.

Pursuant to Regulation 52(7) & 52(7A) of SEBI LODR, please find attached statement of utilisation and statement of deviation for quarter ended September 30, 2026.

Pursuant to Regulation 52(7) & 52(7A) of SEBI LODR, please find attached statement of utilisation and statement of deviation for quarter ended September 30, 2026.

Pursuant to Regulation 52(7) & 52(7A) of SEBI LODR, please find attached statement of utilisation and statement of deviation for quarter ended September 30, 2026.

Announcement under Regulation 30(LODR)- Press Release

Unaudited Results for Q2 FY 2026-27

Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, please find attached the transcript of the earnings conference call held on October 29, 2026, for the quarter ended on September 30, 2026.

Appointment of Mr. Rajat Mishra as Chief Business Officer and Retirement of Mr. Ashok Mehra as President - Chief Marketing Officer

Pursuant to SEBI Listing Regulations, please find enclosed copies of newspaper publication with respect of Unaudited Financial Results for the quarter and six months ended 30th September, 2026.